Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysis

Reproductive Toxicology

Volumn 25, Issue 2, 2008, Pages 271-275

  Rahimi, Roja ^a   Nikfar, Shekoufeh ^b   Rezaie, Ali ^c   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

5 ASA drugs; Congenital abnormalities; Inflammatory bowel disease; Low birth weight; Pregnancy; Preterm delivery; Spontaneous abortion; Stillbirth

Indexed keywords

BALSALAZIDE; MESALAZINE; OLSALAZINE; SALAZOSULFAPYRIDINE;

APHAKIA; ARTICLE; ATRESIA; CEREBRAL PALSY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONGENITAL HIP DISLOCATION; DATA BASE; DEVELOPMENTAL DISORDER; DRUG EXPOSURE; ENTERITIS; FEMALE; FUNNEL CHEST; HIP MALFORMATION; HUMAN; HYDROCELE; HYPOSPADIAS; JAW DISEASE; LARYNGOTRACHEOMALACIA; LOW BIRTH WEIGHT; MACROCEPHALY; MAJOR CLINICAL STUDY; META ANALYSIS; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PLAGIOCEPHALY; POLAND SYNDROME; POLYDACTYLY; PREGNANCY OUTCOME; PREMATURE LABOR; PUBLICATION; RISK ASSESSMENT; SIDE EFFECT; SKIN DISCOLORATION; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; TRACHEOMALACIA; UMBILICAL HERNIA; VARICOSIS;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIRTH WEIGHT; FEMALE; FETAL DEATH; FETUS; HUMANS; INFLAMMATORY BOWEL DISEASES; MESALAMINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 39749151003     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2007.11.010     Document Type: Article

References (24)

1. Kroser J., and Srinivasan R. Drug therapy of inflammatory bowel disease in fertile women. Am J Gastroenterol 101 (2006) S633-S639
2. Mottet C., Juillerat P., Gonvers J.J., et al. Pregnancy and Crohn's disease. Digestion 71 (2005) 54-61
3. Klotz U. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet 10 (1985) 285-302
4. Diav-Citrin O., Park Y.H., Veerasuntharam G., et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114 (1998) 23-28
5. Norgard B., Fonager K., Pedersen L., Jacobsen B.A., and Sorensen H.T. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 52 (2003) 243-247
6. Moskovitz D.N., Bodian C., Chapman M.L., et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 99 (2004) 656-661
7. Norgard B., Pedersen L., Christensen L.A., and Sorensen H.T. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 102 (2007) 1406-1413
8. Baiocco P.J., and Korelitz B.I. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 6 (1984) 211-216
9. Mogadam M., Dobbins III W.O., Korelitz B.I., and Ahmed S.W. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 80 (1981) 72-76
10. Willoughby C.P., and Truelove S.C. Ulcerative colitis and pregnancy. Gut 21 (1980) 469-474
11. Ida A., and Koyama K. Ulcerative colitis and pregnancy. Nippon Rinsho 57 (1999) 2603-2607
12. Trallori G., d'Albasio G., Bardazzi G., et al. 5-Aminosalicylic acid in pregnancy: clinical report. Ital J Gastroenterol 26 (1994) 75-78
13. Habal F.M., Hui G., and Greenberg G.R. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 105 (1993) 1057-1060
14. Nielsen O.H., and Munck L.K. Drug insight: aminosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 160-170
15. Marteau P., Tennenbaum R., Elefant E., Lemann M., and Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 12 (1998) 1101-1108
16. Newman N.M., and Correy J.F. Possible teratogenicity of sulphasalazine. Med J Aust 1 (1983) 528-529
17. Tennenbaum R., Marteau P., Elefant E., et al. Pregnancy outcome in inflammatory bowel diseases. Gastroenterol Clin Biol 23 (1999) 464-469
18. Cornish J., Tan E., Teare J., et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56 (2007) 830-837
19. Katz J.A., and Pore G. Inflammatory bowel disease and pregnancy. Inflamm Bowel Dis 7 (2001) 146-157
20. Connell W., and Miller A. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf 21 (1999) 311-323
21. Rezaie A., Taghavi-Bayat B., and Abdollahi M. Biologic management of fistulizing Crohn's disease. Int J Pharmacol 1 1 (2005) 17-24
22. Rahimi R., Nikfar S., Rezaie A., and Abdollahi M. A meta-analysis of antibiotic therapy for active ulcerative colitis. Dig Dis Sci 52 11 (2007) 2920-2925
23. Rahimi R., Nikfar S., Rezaie A., and Abdollahi M. A meta-analysis of broad spectrum antibiotic therapy in patients with active Crohn's disease. Clin Ther 28 12 (2006) 1983-1988
24. Elahi B., Nikfar S., Derakhshani S., Vafaie M., and Abdollahi M. On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci (2007) [Epub ahead of print]